Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Interest & Investment Income (2024 - 2025)

BioAge Labs (BIOA) has disclosed Interest & Investment Income for 2 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 31.82% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Dec 2025, up 35.9% year-over-year, with the annual reading at $13.1 million for FY2025, 35.9% up from the prior year.
  • Interest & Investment Income hit $2.8 million in Q4 2025 for BioAge Labs, down from $3.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.1 million in Q4 2024 to a low of $1.3 million in Q1 2024.